Australia's Lumigenix Launches DTC Genomics Offering | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Lumigenix has launched what it said is the first personal genomics testing service provided directly to consumers in Australia.

The private California firm, which is owned by an Australian parent, has launched a saliva sample testing kit that provides information about predisposition to common diseases, traits such as caffeine metabolism and taste perception, and ancestry information based on haplogroups.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.